Year: 2011
Type: article
Abstract: In the first half of the 20th century, the polio pandemic spread across much of the world, afflicting hundreds of thousands each year. Mounting a response to this global health crisis required consensus, common language, and dedication among lawmakers, philanthropists, industrialists, patient advocates, and healthcare providers. A diverse group from many industries, both public and private, collaborated to develop a comprehensible message that defined the problem of polio, described its prevalence and mortality, and communicated the barriers to diagnosing and treating it effectively. Together this group led an effort to develop treatment strategies that, fifty years later, have nearly eradicated this devastating and lethal disease. There is another pandemic today that, like polio, requires a concerted effort across multiple business sectors to be defeated. Sepsis may be the final common pathway to death from most infections, and is estimated to kill tens of millions of people worldwide annually. In the United States alone, approximately 215,000 die of sepsis each year—more than breast cancer, colon cancer, and HIV/AIDS combined (1–4). Despite these staggering losses, few specific therapeutic options are available to treat sepsis (4,5). Significant improvements have been made using evidence-based patient
Source: Molecular Medicine
Author: Christopher J. Czura
Institutions: Northwell Health, Feinstein Institute for Medical Research
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W2207634473
